Causes and Risk Factors
ILC begins when cells in the lobules of the breast develop mutations in their DNA. This causes the cells to grow and divide quickly. The growth within the lobule is called in situ carcinoma. When the cells from lobular carcinoma spread outwards, they tend to do so in a single file creating a web-like structure. At this point, the cancer has the potential to become metastatic.
Risk factors for ILC include age, a diagnosis of lobular carcinoma in situ, family history of breast cancer, and genetic markers. These factors are out of a woman’s control. Those who know they have risk factors can educate themselves and work towards prevention and early detection.
Prevention
To prevent the formation of ILC, women should maintain a generally healthy lifestyle. Avoiding over consumption of alcohol, exercising regularly, and keeping a healthy weight are good ways to prevent cancer of any type. Specifically for breast cancer, women who are candidates for hormone therapy should discuss the risks with their doctor before undertaking it. Hormones can increase the risk of developing breast cancer.
Treatment
Because ILC is invasive and can become metastatic, treatment is often aggressive. One option is surgery to remove the cancerous tissue and a small portion of healthy tissue surrounding it. This allows the woman to keep most of her breast tissue intact. Some women may choose to undergo a mastectomy, which removes the whole breast. Lymph nodes under the arms may also need to be removed, as this is where the cancerous cells will spread first. A doctor will determine if the cancer is in the lymph nodes or not.
Another option is chemotherapy. This involves taking a drug that kills cancerous as well as healthy cells. It can be given intravenously or in pill form. Chemotherapy may be done before surgery to shrink the tumor. Side effects of chemotherapy can be very uncomfortable because the drug kills cells indiscriminately.
Radiation therapy uses a beam of X-rays focused on the carcinoma to kill cancerous cells. It is often used after surgery to kill any remaining tumor cells. Hormone therapy may be an option if the cancer is fueled by estrogen. If so, drugs can be used to block estrogen from getting to the tumor.
With a strong support group, information, and collaboration with a doctor, a diagnosis of ILC does not have to be devastating. Prevention, treatment, and support can give a woman with ILC a long and comfortable life.


Add new comment